跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确研究二元工具变量识别的服从者因果效应,并以分位数刻画效应。

反馈分类问题

Estimation of Causal Quantile Effects with a Binary Instrumental Variable and Censored Data

二元工具变量与删失数据下的因果分位数效应估计

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Bo Wei
Limin Peng
Mei-Jie Zhang
Jason P. Fine

二元工具变量与删失数据下的因果分位数效应估计

研究问题
在存在未观测混杂且结局随机删失时,如何利用二元工具变量识别并估计服从者分位数因果效应?
方法与思路
作者结合二元工具变量特征与条件得分原理推导权重,先非参数估计权重,再嵌入标准删失分位数回归。
材料陈述的贡献
摘要称,删失下该效应比服从者平均因果效应所需识别条件更弱,并建立渐近性质、开展模拟及移植数据应用。
阅读关注点
应核对服从者效应的定义、工具变量与删失假设、较弱识别条件的比较基准,以及权重估计对第二阶段推断的影响。
阅读边界
仅据所给 Crossref 摘要,不能补出具体识别假设或稳健性范围,也无法判断模拟数值及临床应用的效应结果。

原文摘要

Abstract The causal effect of a treatment is of fundamental interest in the social, biological and health sciences. Instrumental variable (IV) methods are commonly used to determine causal treatment effects in the presence of unmeasured confounding. In this work, we study a new binary IV framework with randomly censored outcomes where we propose to quantify the causal treatment effect by the concept of complier quantile causal effect (CQCE). The CQCE is identifiable under weaker conditions than the complier average causal effect when outcomes are subject to censoring, and it can provide useful insight into the dynamics of the causal treatment effect. Employing the special characteristic of the binary IV and adapting the principle of conditional score, we uncover a simple weighting scheme that can be incorporated into the standard censored quantile regression procedure to estimate CQCE. We develop robust non-parametric estimation of the derived weights in the first stage, which permits stable implementation of the second stage estimation based on existing software. We establish rigorous asymptotic properties for the proposed estimator, and confirm its validity and satisfactory finite-sample performance via extensive simulations. The proposed method is applied to a bone marrow transplant data set to evaluate the causal effect of rituximab in diffuse large B-cell lymphoma patients.

笔记与分组
相关领域论文